Analyst Recommendations

Overweight Recommendation Issued On SYM By KeyBanc
KeyBanc analyst issues OVERWEIGHT recommendation for SYM on February 18, 2026 10:44PM ET. The previous analyst recommendation was Overweight.SYM was trading at $54.01 at issue of the analyst...

February 18, 2026   SYM 3.50%

Outperform Recommendation Issued On NVDA By RBC Capital
RBC Capital analyst issues OUTPERFORM recommendation for NVDA on February 18, 2026 08:32PM ET. The previous analyst recommendation was Outperform.NVDA was trading at $187.98 at issue of the...

February 18, 2026   NVDA -0.66%

Outperform Recommendation Issued On PANW By Scotiabank
Scotiabank analyst issues OUTPERFORM recommendation for PANW on February 18, 2026 02:47PM ET. The previous analyst recommendation was Outperform.PANW was trading at $152.04 at issue of the analyst...

February 18, 2026   PANW 5.53%

Outperform Recommendation Issued On PANW By BMO Capital
BMO Capital analyst issues OUTPERFORM recommendation for PANW on February 18, 2026 02:04PM ET. The previous analyst recommendation was Outperform.PANW was trading at $149.475 at issue of the...

February 18, 2026   PANW 5.53%

Buy Recommendation Issued On PANW By Needham
Needham analyst issues BUY recommendation for PANW on February 18, 2026 12:15PM ET. The previous analyst recommendation was Buy.PANW was trading at $163.5 at issue of the analyst...

February 18, 2026   PANW 5.53%

Overweight Recommendation Issued On PANW By Morgan Stanley
Morgan Stanley analyst issues OVERWEIGHT recommendation for PANW on February 18, 2026 11:35AM ET. The previous analyst recommendation was Overweight.PANW was trading at $163.5 at issue of the...

February 18, 2026   PANW 5.53%

Neutral Recommendation Issued On AVAV By UBS
UBS analyst issues NEUTRAL recommendation for AVAV on February 18, 2026 10:20AM ET. AVAV was trading at $262.99 at issue of the analyst recommendation.The overall analyst consensus :...

February 18, 2026   AVAV -5.95%

Buy Recommendation Issued On CGNX By Cowen & Co.
Cowen & Co. analyst issues BUY recommendation for CGNX on February 17, 2026 01:38PM ET. The previous analyst recommendation was Buy.CGNX was trading at $58.79 at issue of...

February 17, 2026   CGNX 2.57%

Neutral Recommendation Issued On CRM By UBS
UBS analyst issues NEUTRAL recommendation for CRM on February 17, 2026 01:49PM ET. The previous analyst recommendation was Neutral.CRM was trading at $189.72 at issue of the analyst...

February 17, 2026   CRM -2.45%

Outperform Recommendation Issued On CRM By Oppenheimer
Oppenheimer analyst issues OUTPERFORM recommendation for CRM on February 17, 2026 12:53PM ET. The previous analyst recommendation was Outperform.CRM was trading at $189.72 at issue of the analyst...

February 17, 2026   CRM -2.45%